Literature DB >> 7781370

Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock.

P E Bollaert1, B Levy, L Nace, P F Laterre, A Larcan.   

Abstract

STUDY
OBJECTIVE: To examine the hemodynamic and metabolic short-term effects of hypophosphatemia correction in patients with septic shock receiving catecholamine therapy.
DESIGN: Prospective, single cohort study.
SETTING: ICU, university hospital. PATIENTS: Ten patients with septic shock and hypophosphatemia below 2 mg/dL.
INTERVENTIONS: Infusion of glucose-1-phosphate solution (20 mmol of elemental phosphorus) for 60 min. MEASUREMENTS AND
RESULTS: Hemodynamic, oxygen-derived, acid-base, and electrolyte parameters before and immediately after phosphate infusion. Left ventricular stroke work index increased significantly (22%) from a mean low value of 24 +/- 10 g/m2 without changes in filling pressures. Systolic arterial pressure improved by 12%. Arterial pH improved slightly but significantly. Ionized calcium level slightly decreased within the normal range values. Other parameters remained unchanged.
CONCLUSIONS: Severe hypophosphatemia may be considered as a superimposed cause of myocardial depression, inadequate peripheral vasodilatation, and acidosis in septic shock. A rapid correction of hypophosphatemia is well tolerated and may have both myocardial and vascular beneficial effects. The magnitude of the response, however, is variable and unpredictable on the basis of serum phosphorus levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781370     DOI: 10.1378/chest.107.6.1698

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Association between Hypophosphatemia and Cardiac Arrhythmias in the Early Stage of Sepsis: Could Phosphorus Replacement Treatment Reduce the Incidence of Arrhythmias?

Authors:  Andrei Schwartz; Evgeni Brotfain; Leonid Koyfman; Ruslan Kutz; Shaun E Gruenbaum; Moti Klein; Alexander Zlotnik
Journal:  Electrolyte Blood Press       Date:  2014-06-30

Review 2.  Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies.

Authors:  Valentina Pistolesi; Laura Zeppilli; Enrico Fiaccadori; Giuseppe Regolisti; Luigi Tritapepe; Santo Morabito
Journal:  J Nephrol       Date:  2019-09-12       Impact factor: 3.902

3.  Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia.

Authors:  Thierry Charron; Francis Bernard; Yoanna Skrobik; Nathalie Simoneau; Nadine Gagnon; Martine Leblanc
Journal:  Intensive Care Med       Date:  2003-07-05       Impact factor: 17.440

Review 4.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

5.  Incidence and aetiology of renal phosphate loss in patients with hypophosphatemia in the intensive care unit.

Authors:  Anneke Bech; Michiel Blans; Darryl Telting; Hans de Boer
Journal:  Intensive Care Med       Date:  2013-07-20       Impact factor: 17.440

6.  Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy.

Authors:  M Broman; O Carlsson; H Friberg; A Wieslander; G Godaly
Journal:  Acta Anaesthesiol Scand       Date:  2010-10-29       Impact factor: 2.105

7.  Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy.

Authors:  Su-Young Jung; Hyunwook Kim; Seohyun Park; Jong Hyun Jhee; Hae-Ryong Yun; Hyoungnae Kim; Youn Kyung Kee; Chang-Yun Yoon; Hyung Jung Oh; Tae Ik Chang; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Hajeong Lee; Dong Ki Kim; Seung Hyeok Han
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Impaired cardiac and neurological function with mild hypophosphatemia during insulin therapy for diabetic ketoacidosis and marked improvement with phosphate supplementation: A case report.

Authors:  Tomohiko Yoshida; Minoru Takemoto
Journal:  J Diabetes Investig       Date:  2020-08-12       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.